科研之友
微信
新浪微博
Facebook
分享链接
摘要
The process of allogeneic HSCT in children is associated with frequent AKI and mortality, but the epidemiology is not widely reported. The aim of this review was to summarize the available evidence on incidence, risk factors, timing, and prognosis of AKI in children following HSCT. We systematically reviewed all observational studies reporting incidence and outcomes of AKI in pediatric allogenic HSCT recipients. The minimum criteria for AKI were defined as an increase in sCr x1.5 or urine output 0.5mL/kg/min over sixh. Medline and Embase were searched until March 2014. From 993 electronic records, five were eligible for inclusion (n=571 patients). The average incidence of AKI within the first 100days following HSCT was 21.7% (range 11-42%), and the average time of onset was 4-6wk post-transplant. Risk factors for AKI included cyclosporine toxicity, amphotericin B and foscarnet, SOS, and having a mismatched donor. There were conflicting reports on whether AKI was associated with the development of CKD. AKI is a common and potentially life-threatening complication following HSCT in children. Further quality observational studies are needed to accurately determine the epidemiology and prognosis of AKI in this population.
- 出版日期2015-8
